Elanco CFO granted 8 deferred stock units at $24.50

Elanco’s CFO received a small grant of deferred stock units tied to common stock or cash value.

Rhea-AI Filing Summary

Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc (ELAN) reported that its EVP and CFO, Robert M. VanHimbergen, received a grant of 8.0416 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, bringing his directly held deferred stock units to 149.8658.

Insider Trade Summary

Grant/Award: 8.0416 shares

Grant/Award 1 txn

Insider VanHimbergen Robert M

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units F1, F2	8.0416	$24.50	$197.02

Holdings After Transaction: Deferred Stock Units — 149.8658 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred Stock Units granted: 8.0416 units Reference value per Deferred Stock Unit: $24.50 per unit Deferred Stock Units held after transaction: 149.8658 units

3 metrics

Deferred Stock Units granted 8.0416 units Grant to EVP and CFO Robert M. VanHimbergen on September 4, 2026

Reference value per Deferred Stock Unit $24.50 per unit Value reported for the September 4, 2026 grant

Deferred Stock Units held after transaction 149.8658 units Directly held by EVP and CFO Robert M. VanHimbergen after the grant

Key Terms

Deferred Stock Units, cash equivalent, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

cash equivalent financial

"right to receive one share of Company common stock or the cash equivalent"

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

FAQ

What insider transaction did ELAN report for CFO Robert M. VanHimbergen?

Elanco Animal Health reported that EVP and CFO Robert M. VanHimbergen received a grant of 8.0416 Deferred Stock Units on September 4, 2026, as a compensation-related award linked to the company’s common stock or its cash equivalent.

How many deferred stock units does the ELAN CFO hold after this Form 4 transaction?

After the September 4, 2026 grant, EVP and CFO Robert M. VanHimbergen holds 149.8658 Deferred Stock Units directly, each tied to a right to receive one share of Elanco common stock or the cash equivalent.

What is the reference price for the Elanco (ELAN) deferred stock units granted?

The 8.0416 Deferred Stock Units granted to the Elanco CFO on September 4, 2026 carry a reported value of $24.50 per unit, with each unit representing the right to receive one share of common stock or an equivalent cash amount.

How are Elanco (ELAN) deferred stock units settled for the CFO’s grant?

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. The units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Was the Elanco CFO’s September 2026 deferred stock unit grant under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed, meaning the September 4, 2026 grant of 8.0416 Deferred Stock Units to the Elanco CFO is not reported as being made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 05:11 PM Accepted by SEC EDGAR 09/09/2026 - 05:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	09/04/2026		A		8.0416		(2)	(2)	Common Stock	8.0416	$24.5	149.8658	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)